Ultralife Corporation
ULBI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $43 | $49 | $51 | $44 |
| % Growth | -10.7% | -4.3% | 15.7% | – |
| Cost of Goods Sold | $34 | $37 | $38 | $33 |
| Gross Profit | $10 | $12 | $13 | $11 |
| % Margin | 22.2% | 23.9% | 25.1% | 24.2% |
| R&D Expenses | $3 | $2 | $2 | $2 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $8 | $7 | $7 | $7 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $11 | $9 | $9 | $9 |
| Operating Income | -$1 | $2 | $3 | $1 |
| % Margin | -2.2% | 4.6% | 6.7% | 3.4% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$1 |
| Pre-Tax Income | -$2 | $1 | $2 | $0 |
| Tax Expense | -$1 | $0 | $1 | $0 |
| Net Income | -$1 | $1 | $2 | $0 |
| % Margin | -2.8% | 1.8% | 3.7% | 0.4% |
| EPS | -0.073 | 0.053 | 0.11 | 0.012 |
| % Growth | -238.8% | -52% | 840.2% | – |
| EPS Diluted | -0.073 | 0.053 | 0.11 | 0.012 |
| Weighted Avg Shares Out | 17 | 17 | 17 | 17 |
| Weighted Avg Shares Out Dil | 17 | 17 | 17 | 17 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $1 | $4 | $5 | $3 |
| % Margin | 1.5% | 7.3% | 9.5% | 5.7% |